Connor, Clark & Lunn Investment Management (CC&L)’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,152
Closed -$27K 1291
2021
Q4
$27K Buy
+21,152
New +$42.4K ﹤0.01% 1052

Other funds holding TLMD

Connor, Clark & Lunn Investment Management (CC&L)'s TLMD Position: Q1 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q1 2022, closing a stake of 21,152 shares — an estimated $27K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TLMD in Q4 2021 and held it in 1 quarter. The position peaked at $27K in Q4 2021. 80 funds tracked by Wall St. Rank hold TLMD as of Q1 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 21,152 SOC Telemed, Inc. Class A Common Stock shares in Q1 2022, an estimated $27K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s SOC Telemed, Inc. Class A Common Stock position peaked at $27K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q1 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.